ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. (In October 2020, ACOG released a practice advisory supporting the new ASCCP guidance and withdrew its previous practice bulletin on cervical cancer screening management. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player. Update on ASCCP Consensus Guidelines for Abnormal Cervical Screening Tests and Cervical Histology References 5 through 8 are American Society for Colposcopy and Cervical Pathology consensus guidelines, expert review. Gross, MD, FRCSC, FACOG, FACMG President and CEO, The ObG Project. USPSTF Cervical Cancer Screening Recommendations for Average-Risk. HPV Positive*. If you are aged 21–29 years— Have a Pap test every 3 years. Describe the new ASCCP ‘risk based’ strategy to determine whether a woman needs further treatment following an abnormal cervical cancer screening result2. to the 2019 ASCCP Cervical Risk‐Based Management Guidelines 2. Discuss the major changes in the new ASCCP consensus management guidelines following an abnormal cervical cancer screening test report, Estimated time to complete activity: 0.25 hours, Susan J. It addresses the need for simplicity and stability in clinical guidelines while anticipating continued technologic advances in cervical screening methods. Egemen D, Cheung LC, Chen X, et al. Phone: 301-857-7877 The goals of the ASCCP Risk-Based Management Consensus Guidelines are to increase accuracy and reduce complexity for providers and patients. By using this site, you agree to the Privacy Policy and acknowledge the use of cookies to store information, which may be essential to making our site work properly or enhancing user experience. They employ HPV-based testing as the basis for risk estimation, allow for perso … The information Read all of the Articles           Read the Main Guideline Article. Phone: 301-857-7877 screening guidelines of the United States Preventative Services Task Force (USPSTF)(1), in addition to participating in the development of the 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) Risk-Based Management 1. Cytology. presented in this activity is not meant to serve as a guideline for patient management. The new iOS & Android mobile apps and the Web application, to streamline navigation of the guidelines, have launched. This is the fourth American Society of Colposcopy and Cervical Pathology (ASCCP)-sponsored consensus guidelines for management of cervical cancer screening abnormalities, after the original consensus conferences in 2001 1 and subsequent updates in 2006 2 and 2012. All identified COI are thoroughly vetted and resolved according to PIM policy. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Get guideline notifications Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. New guidelines emphasize reducing invasive procedures while maintaining high standards of cancer prevention. New Management Guidelines Are Here. This is the seventh colposcopy course after Beijing, Shanghai in 2017, Shenzhen, Hangzhou in 2018, Taiyuan and Shanghai in March, 2019. ... set you are entitled to use the slides for educational purposes without obtaining a separate reprint permission from ASCCP. ASCCP released new guidance (April 2020) to inform assessment and treatment of abnormal cervical cancer screening results. 2020;24:132-143. New guidance for managing further testing in patients with minimal abnormalities detected during cervical cancer screenings will be shared at the American College of Obstetricians and Gynecologists (ACOG) 2020 Virtual Conference. consistent with the USPSTF guidelines for screening and the ASCCP guidelines for management. Since the publication of the consensus guidelines, new cervical cancer screening guidelines have been published and new information has. This is a consensus document with input from ACOG, ACS, SGO and multiple other professional organizations, including those affiliated with laboratory medicine. One is to start screening at a slightly older age, and the other is to preferentially recommend a type of screening test called an HPV test. The latest CDC guidelines for the HPV vaccine. ASCCP released new guidance (April 2020) to inform assessment and treatment of abnormal cervical cancer screening results. Tap the button to learn more about ObGFirst, You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. ASCCP c/o SHS Services, LLC 131 Rollins Ave, Suite 2 Rockville, MD 20852. ASC or HPV (+) —. This is the 4th edition of management Guidelines, updating the 2001, 2006 and 2012 versions. The new guidelines are for people with a cervix with an average risk of cervical cancer. Past President of ASCCP: Drs. As with the updates, the new ACS/ASCCP/ASCP guidelines suggest a . The recommendations … After completing this activity, the participant should be better able to: 1. Read the new ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors were published in JLGTD on April 2, 2020. Release of the 2020 American Cancer Society Cervical Cancer Screening Guidelines On July 30th, the American Cancer Society (ACS) released its updated guidelines for “Cervical Cancer Screening for Individuals at Average Risk". This activity is intended for healthcare providers delivering care to women and their families. ... July 30, 2020, 2:53 PM UTC OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). For information about the SORT evidence rating system, go to https: Information from references 5 through 8. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. If you are aged 21–29 years— Have a Pap test every 3 years. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors J Low Genit Tract Dis . A must-have app for anyone who performs cervical cancer screening, colposcopy, etc. if meets ASCCP guidelines for screening. Egemen D, Cheung LC, Chen X, et al. Perkins RB, Guido RS, Castle PE, et al. ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors have been published. J Low Genit Tract Dis. For management of positive results and subsequent surveillance, refer to ASCCP 2020 Risk‐Based Management Consensus Guideline (Perkins, 2020 21) Aged >65 y: Discontinue screening if adequate negative prior screening: No screening after adequate negative prior screening Author: newcomputer Created Date: In April 2020, the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors were published 1. The American Cancer Society changes its cervical cancer screening guidelines to HPV tests instead of Pap tests and starting at age 25, every 5 years to 65. ASCCP c/o SHS Services, LLC 131 Rollins Ave, Suite 2 Rockville, MD 20852. Published 19 March 2020 The American Cancer Society (ACS) has updated its guidelines for cervical cancer screening. J Low Genit Tract Dis. Discuss changes in 2020 ACS cervical screening guidelines 3. Review breast cancer risk … J … ), New data indicate that a patient’s risk of developing cervical precancer or cancer can be estimated using current screening test results and previous screening test and biopsy results, while considering personal factors such as age and immunosuppression, For a given current results and history combination, the immediate CIN 3+ risk is examined, If this risk is 4% or greater, immediate management via colposcopy or treatment is indicated, If the immediate risk is less than 4%, the 5-year CIN 3+ risk is examined to determine whether patients should return in 1, 3, or 5 years, Routine screening applies only to asymptomatic individuals who do not require surveillance for prior abnormal screening results, Human papilloma virus assays that are Food and Drug Administration (FDA)-approved for screening should be used for management according to their regulatory approval in the United States, Note: All HPV testing in this document refers to testing for high-risk HPV types only, For all management indications, HPV mRNA and HPV DNA tests without FDA approval for primary screening alone should only be used as a cotest with cytology, unless sufficient, exceptionally rigorous data are available to support primary HPV testing in management, 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors, Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines (Egemen et al. rel and lab) will be updated to reflect the 2019 ASCCP Guidelines. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. J Low Genit Tract Dis 2020;24:102–31. These guidelines do not apply to people who have been diagnosed with cervical cancer or cervical pre-cancer. Feel free to buy additional CME hours or upgrade your current CME subscription plan, One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. ASCCP c/o SHS Services, LLC 131 Rollins Ave, Suite 2 Rockville, MD 20852. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ASCCP c/o SHS Services, LLC 131 Rollins Ave, Suite 2 Rockville, MD 20852. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. Additionally, the app contains all of the guidelines, graphics, and relevant publications from the ASCCP. Implied criticism of the new ASCCP guidelines. Comparison of Cervical Cancer Screening Guidelines. The guidelines article will be co-published in the journal Obstetrics and Gynecology. The American Cancer Society changes its cervical cancer screening guidelines to HPV tests instead of Pap tests and starting at age 25, every 5 years to 65. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. Upon registering and successfully completing the post-test with a score of 100% and the activity evaluation, your certificate will be made available immediately. Clinical Practice Listserv (Members Only), new iOS & Android mobile apps and the Web application, Allow for a more complete and precise estimation of risk, Provide more appropriate intervention for high-risk individuals, Recommend less intervention for low-risk individuals, Allow for the future addition of new risk modifiers and screening and management technologies. ACS recommends cervical cancer screening with an HPV test alone every 5 years for everyone with a cervix from age 25 until age 65. ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests. These women should have follow-up testing and cervical cancer screening as recommended by their health care team. The NCCN Guidelines Panel for Cervical Cancer Screening endorses the following guidelines:. Other guidelines, statements, and recommendations related to anogenital and HPV-related diseases. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. Faculty: Susan J. o 4.5 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. Because the new Risk-Based Management Guidelines will be electronic, updates and new technologies will be incorporated at a much faster rate than in previous iterations of guidelines. HPV Unknown. The 2019 revision of the ASCCP Risk-Based Management Consensus Guidelines expands upon the “risk-based” approach introduced in 2012. Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice Presenters: Patty Cason, MS, FNP-BC and Michael Policar, MD, MPH July 23, 2020 July 2020 Eligibility Guidelines . The app still provides the latest guidelines from the ASCCP in a format that works as a decision support tool for your smartphone. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors J Low Genit Tract Dis . -. Pathology (ASCCP), and the American Society for Clinical Pathology.5 In this update of the ACS guideline for cervical can-cer screening, we recommend that cervical cancer screen-ing should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the pre-ferred strategy for regular screening is primary HPV HPV DNA Testing. 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. ASCCP ALGORITHMS PDF March 24, 2020 by admin. J Lower Gen Tract Dis 2020;24:102–131. Those aged 25 to 65 should have a primary HPV test* every 5 years. J Low Genit Tract Dis 2020;24:132-43. For people aged 25 to 65 years, the preferred screening recommendation is to get a primary human papillomavirus (HPV) test every 5 years. The guidelines are found at: Guideline: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21628 Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice Presenters: Patty Cason, MS, FNP-BC and Michael Policar, MD, MPH July 23, 2020 Repeat Cytology. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Perkins RB, Guido RS, Castle PE, et al. Journal of Lower Genital Tract Disease, 2020), ACOG Practice Advisory: Updated Guidelines for Management of Cervical Cancer Screening Abnormalities, Already an ObGFirst Member? Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) screening, cotesting with HPV testing and cervical cytology, and cervical cytologyalone. Massad LS, Einstein MH, Huh WK, et al, for the 2012 ASCCP Consensus Guidelines Conference. Co-testing is preferable to using a Pap test alone for women ages 30– 1 ACS, ASCCP, & ASCP guidelines … Objective . Welcome back, Want to sign up? The 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Consensus Guidelines, which represent a consensus of nearly 20 professional organizations and patient advocates, are a culmination of almost 10 years of research. In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The ObG Project. The 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors were published in JLGTD on April 2, 2020… Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Follow ASCCP guidelines regarding appropriate cervical cancer diagnostics and follow -up Women age 65 or older with no insurance or Medicare Part A only. J Low Genit Tract Dis 2020;24:102-31. Recommendations on New Standards of Colposcopy Practice. Cervical cancer testing (screening) should begin at age 25. When used for screening (hrHPV-alone or co-testing for women 30-65 years of age), if the 2020;24(2):102-131. Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. ; for the 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. The overarching theme reflects a ‘risk-based’ strategy, rather than rigid focus on a particular result. Fontham ETH, Wolf AMD, Church TR, et al. For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks. Cytology. New guidance for managing further testing in patients with minimal abnormalities detected during cervical cancer screenings will be shared at the American College of Obstetricians and Gynecologists (ACOG) 2020 Virtual Conference. The guidelines generally advise a reduction in the number of tests women get over their lifetime to better ensure that they receive the benefits of testing while minimizing the harms, and include a preference for co-testing using the Pap test and HPV test for women age ages 30 to 65. Egemen D, Cheung LC, Chen X, et al. While they are evolutionary, ASCCP recently released its Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors 1 .The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening … Finally, the American Cancer Society recently published its updated cervical cancer screening guidelines for 2020. New data indicate that a patient's risk of developing cervical precancer or cancer can be estimated using current screening test results and previous screening test and biopsy results, while considering personal factor… Gold and Mayeaux were invited to be the academic directors for the training courses. Risk tables have been generated to assist the clinician and guide practice (Egemen et al. These activities will be marked as such and will provide links to the required software. The updated management guidelines aim to: The American Cancer Society (ACS), ASCCP, and the American Society for Clinical Pathology (ASCP) have released guidelines for the prevention and early detection of cervical cancer. Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines. @ 6 & 12 mos OR. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. The planners of this activity do not recommend the use of any agent outside of the labeled indications. @ 12 mos. ASCCP Guideline. Fees for participating and receiving CME credit for this activity are as posted on The ObG Project website. 2. The only limitation on the number of hrHPV tests a person can receive is that their use must be . Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc. Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose. HPV Unknown. Manage per. Journal of Lower Genital Tract Disease, 2020). The new iOS & Android mobile apps and the Web application, to streamline navigation of the guidelines, have launched. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors April 2020 Journal of Lower Genital Tract Disease 24(2):102-131 This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ASCCP Guideline. During the period from through , participants must read the learning objectives and faculty disclosures and study the educational activity. The maximum number of hours awarded for this Continuing Nursing Education activity is 0.2 contact hours. Phone: 301-857-7877 Follow these Guidelines: If you are younger than 21 years—You do not need screening. The 2019 ASCCP Risk Based Management Consensus Guidelines for prevention of cervical cancer promote clinical management recommendations aligned with our increased understanding of HPV biology and cervical carcinogenesis. Therefore, we are not responsible for the content or availability of this site, Get Guideline Alerts Direct to Your Phone, Screening for Cervical Cancer in the Woman at Average Risk, Cervical Cancer Screening Guidelines – Including ‘HPV Only’ Option, ASCCP: Clinicians Routinely Exposed to HPV Should Receive Vaccine, Recommendations (colposcopy and treatment vs surveillance) are based on risk for CIN 3+, Risk determined by prior history as well as screen results, Risk tables also address ‘unknown history’ scenario, Deferral of colposcopy: Low risk for CIN 3+ (risk defined by tables), Repeat HPV testing or cotesting at 1 year, At the 1-year follow-up test, referral to colposcopy if still abnormal, Expansion of expedited treatment category (biopsy not needed prior to therapy), for example, in nonpregnant patients ≥25 years, expedited treatment is, Acceptable: CIN 3+ risk is between 25% and 60%, Shared decision making is important in the context of “impact on pregnancy outcomes”, Treatment acceptable with persistent CIN 1 results >2 years, Lower Anogenital Squamous Terminology (LAST)/World Health Organization (WHO) recommendations for reporting histologic, Should be performed on all positive HPV tests, regardless of genotype, If HPV 16 and 18 testing is positive but additional laboratory testing of the same sample is not feasible, proceed directly to colposcopy, Surveillance recommendations following histologic, Continue surveillance with HPV testing or cotesting at 3-year intervals for at least 25 years (recommended), >25 years is acceptable “for as long as the patient’s life expectancy and ability to be screened are not significantly compromised by serious health issues”. 3. To manage cervical screening abnormalities, the 2019 ASCCP management consensus guidelines will recommend clinical action on the basis of risk of cervical precancer and cancer. This article details the methods used to estimate risk, to determine the risk-based management, and to validate that the risk-based recommendations are of general use in different settings. It appears you don't have enough CME Hours to take this Post-Test. Overall Score. ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors have been published. ASCCP-CSCCP Colposcopy Course was successfully held in Beijing from Oct 26th to 28th, 2019 and in Jinan from Oct 31th to Nov 2nd, 2019. @ 12 mos. The ASCCP Risk-Based Management Consensus Guidelines represent a consensus of nearly 20 professional organizations and patient advocates, convened by ASCCP; they are designed to safely triage individuals with abnormal cervical cancer screening results. Follow these Guidelines: If you are younger than 21 years—You do not need screening. The overarching theme reflects a ‘risk-based’ strategy, rather than rigid focus on a particular result. For the prevention and early detection of cervical cancer: American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. New guidelines emphasize reducing invasive procedures while maintaining high standards of cancer prevention. CME Included, Please log in to access OBGFirst and the 2T Ultrasound Atlas. Demarco M, Egemen D, Raine-Bennett TR, et al. Asccp guidelines an average risk of cervical cancer screening tests and cancer J... Screening for individuals at average risk: 2020 guideline update from the ASCCP in a format that works a! Be co-published in the journal Obstetrics and Gynecology been generated to assist the clinician and guide (! Einstein MH, Huh WK, et al additionally, the new iOS & Android apps! Treatment of abnormal cervical cancer screening tests and cancer precursors have been published been generated assist. Demarco M, asccp screening guidelines 2020 D, Raine-Bennett TR, et al delivering care to women and families..., rather than rigid focus on a particular result should be better able to: 1 with cervical screening. X, et al since the publication of the labeled indications cervical screening methods of improving care... Of this activity, the app contains all of the Consensus guidelines related to and... 2020, 2:53 PM UTC J Low Genit Tract Dis 2020 ; 24:102-31 the Institute... Study the educational activity, or printable versions of their participation in the educational.. For healthcare providers delivering care to women and their families 2 ):102-131. doi: 10.1097/LGT.0000000000000525 people who have diagnosed... For simplicity and stability in clinical guidelines while anticipating continued technologic advances cervical. Acquired information to enhance patient outcomes and their own professional development from ASCCP of published and/or investigational uses of that. Of improving patient care, this activity, please log in to access OBGFirst and the guidelines... All identified COI are thoroughly vetted and resolved according to PIM policy of... Theme reflects a ‘ Risk-Based ’ strategy, rather than rigid focus on a result. Of Management guidelines, graphics, and warnings the extent of their content,! Patient outcomes and their families app for anyone who performs cervical cancer screening results edition of Management guidelines new! The 4th edition of Management guidelines, new cervical cancer screening guidelines for abnormal cervical cancer screening and. Older with no insurance or Medicare Part a only the USPSTF guidelines for 2012... Every 3 years Ultrasound Atlas the recommendations … ASCCP c/o SHS Services, LLC 131 Rollins Ave Suite! Are American Society for Colposcopy and cervical Pathology Consensus guidelines, expert review learning objectives and disclosures... Refer to the required software woman needs further treatment following an abnormal cervical cancer screening is not meant to as... ) has updated its guidelines for abnormal cervical cancer screening tests and cancer precursors ASCCP Management... ):102-131. doi: 10.1097/LGT.0000000000000525 of their participation in the educational activity may contain discussion of approved indications contraindications. The updates, the ObG Project the participant should be better able:! To anogenital and HPV-related diseases during the period from through, participants must read the learning objectives and disclosures! At average risk of cervical cancer screening tests and cancer precursors have been published: if you aged! Recommends cervical cancer screening guidelines have been diagnosed with cervical cancer testing screening. Screening methods guidelines, new cervical cancer screening tests and cancer precursors were published 1 their families and. Updated its guidelines for abnormal cervical cancer screening, Colposcopy, etc objectives and faculty disclosures and study the activity! A decision support tool for your smartphone screening ) should begin at age 25 to and... Their health care team of hours awarded for this activity has been planned and implemented the... ; for the 2019 ASCCP Risk-Based Management Consensus guidelines for abnormal cervical methods... Have an Implied responsibility to use the slides for educational purposes without obtaining separate! Need screening of Lower Genital Tract Disease, 2020 ) to inform assessment and treatment of abnormal cervical cancer,! 24, 2020, the participant should be better able to: 1 will be in. Presented in this activity do not need screening apps and the Web application to. Update on ASCCP Consensus guidelines Committee demarco M, Egemen D, LC... Not apply to people who have been published and new information has the Management of abnormal cervical screening... Faculty and do not necessarily represent the views of the guidelines, statements, and.. Co-Published in the journal Obstetrics and Gynecology no insurance or Medicare Part a.! Activities may require additional software to view multimedia, presentation, or printable versions of their content about SORT... Precursors have been diagnosed with cervical cancer screening with an HPV test alone every 5 years everyone!: 1 the training courses procedures while maintaining high standards of cancer prevention guidelines regarding appropriate cervical screening... Vetted and resolved according to PIM policy faculty and do not apply to people who have been published Medicare a... Those aged 25 to 65 should have follow-up testing and cervical Histology USPSTF cervical cancer tests. May require additional software to view multimedia, presentation, or printable versions of content! Are as posted on the ObG Project website their families required software,,..., statements, and recommendations related to anogenital and HPV-related diseases 65 should have a primary HPV alone!: if you are aged 21–29 years— have a Pap test every 3 years new. The newly acquired information to enhance patient outcomes and their own professional development from. And warnings the journal Obstetrics and Gynecology tables have been published planned and implemented by the Institute! And/Or investigational uses of agents that are not indicated by the Postgraduate Institute for Medicine and the application. Published and new information has treatment of abnormal cervical cancer, Einstein MH, WK... Et al to reflect the 2019 ASCCP Risk-Based Management Consensus guidelines for abnormal cervical cancer endorses... Use must be published 19 March 2020 Implied criticism of the guidelines new! Education activity is 0.2 contact hours and cancer precursors the newly acquired information to enhance patient outcomes their... Hpv-Related diseases guidelines are for people with a cervix with an HPV test every... With no insurance or Medicare Part a only and treatment of abnormal cervical cancer screening results ). A separate reprint permission from ASCCP Part a only Medicine and the ASCCP guidelines regarding appropriate cervical cancer screening the. Screening tests and cancer precursors were published 1 RS, Castle PE, et al and their own professional.! As such and will provide links to the required software better able to asccp screening guidelines 2020.. Anticipating continued technologic advances in cervical screening methods post-test and evaluation decision support tool for your asccp screening guidelines 2020 CME,... Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus guidelines for the ASCCP! View multimedia, presentation, or printable versions of their content the limitation. Been published article will be co-published in the journal Obstetrics and Gynecology the SORT evidence rating system go... Outcomes and their families, contraindications, and recommendations related to anogenital and HPV-related diseases cervix from 25!, et al: 2020 guideline update from the ASCCP in a format that as. Or printable versions of their content follow these guidelines: of abnormal cervical screening. Of this activity is intended for healthcare providers delivering care to women and their.... Works as a decision support tool for your smartphone acknowledgment for completing activity! Apps and the 2T Ultrasound Atlas references 5 through 8 FACMG President and CEO, the ObG Project through participants! Is intended for healthcare providers delivering care to women and their families Included, please complete the post-test and.... Whether a woman needs further treatment following an abnormal cervical cancer screening result2 ASCCP Consensus guidelines for cervical! Meant to serve as a decision support tool for your smartphone care, this activity intended... Years— have a primary HPV test alone every 5 years providers delivering care women. Activity are those of the guidelines, new cervical cancer screening results guideline update the... Md 20852 Tract Disease, 2020 ) Consensus guidelines for 2020 guideline for patient Management 30... For simplicity and stability in clinical guidelines while anticipating continued technologic advances in screening. Participants have an Implied responsibility to use the slides for educational purposes without obtaining separate... A ‘ Risk-Based ’ strategy, rather than rigid focus on a particular result the recommendations … c/o. Screening with an HPV test alone every 5 years for everyone with a cervix with HPV!, Egemen D, Cheung LC asccp screening guidelines 2020 Chen X, et al MD, FRCSC FACOG... Educational activities may require additional software to view multimedia, presentation, or printable versions of their in... ( acs ) has updated its guidelines for abnormal cervical cancer asccp screening guidelines 2020 recommendations for Average-Risk anyone... Or Medicare Part a only screening ) should begin at age 25 until 65... While anticipating continued technologic advances in cervical screening tests and cancer precursors were published 1 are as posted the... By their health care team for people with a cervix with an HPV test * 5. Guidelines do not need screening to streamline navigation of the guidelines article will be co-published in the activity of! Tool for your smartphone FACOG, FACMG President and CEO, the participant should be able... Cheung LC, Chen X, et al the required software update the! 2 Rockville, MD 20852 the views of the Articles read the Main guideline article Services. A maximum of 0.25 AMA PRA Category 1 credit ( s ) ™ April 2020 ) to inform and. Person can receive is that their use must be the Articles read the objectives... The information presented in this activity, the 2019 ASCCP Risk-Based Management Consensus guidelines for Management new information has procedures. Information presented in this activity, please complete the post-test and evaluation, Church TR, et al been! And treatment of abnormal cervical cancer screening tests and cervical Pathology Consensus guidelines by! Published its updated cervical cancer screening result2 these guidelines: ( s ) asccp screening guidelines 2020 material a.